Purinergic regulation of angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinase

British Journal of Cancer

Volumn 97, Issue 10, 2007, Pages 1372-1380

  Rumjahn, S M ^a   Javed, M A ^a   Wong, N ^a   Law, W E ^a   Buxton, I L O ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Nucleoside diphosphate kinase; P2Y receptors; Polyphenolic compounds; Tumour angiogenesis

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; 2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; ADENOSINE TRIPHOSPHATE; CD31 ANTIGEN; COLLAGEN; ELLAGIC ACID; EPIGALLOCATECHIN GALLATE; MATRIGEL; NUCLEOSIDE DIPHOSPHATE KINASE; PURINE P2Y RECEPTOR; PURINE P2Y1 RECEPTOR;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER INHIBITION; CELL COUNT; CULTURE MEDIUM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; REGULATORY MECHANISM; TUMOR VASCULARIZATION;

ADENOSINE TRIPHOSPHATE; BREAST NEOPLASMS; CATECHIN; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELLAGIC ACID; ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NUCLEOSIDE-DIPHOSPHATE KINASE; RECEPTORS, PURINERGIC P2; TUMOR CELLS, CULTURED;

EID: 36148931807     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604019     Document Type: Article

References (39)

1. Anzinger J, Malmquist NA, Gould J, Buxton IL (2001) Secretion of a nucleoside diphosphate kinase (Nm23-H2) by cells from human breast, colon, pancreas and lung tumors. Proc West Pharmacol Soc 44: 61-63
2. Backer JM, Mendola CE, Kovesdi I, Fairhurst JL, O'Hara B, Eddy Jr RL, Shows TB, Mathew S, Murty VV, Chaganti RS (1993) Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-1 and NM23-2. Oncogene 8: 497-502
3. Baurand A, Raboisson P, Freund M, Leon C, Cazenave JP, Bourguignon JJ, Gachet C (2001) Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist. Eur J Pharmacol 412: 213-221
4. Bertheau P, De La RA, Steeg PS, Merino MJ (1994) NM23 protein in neoplastic and nonneoplastic thyroid tissues. Am J Pathol 145: 26-32
5. Boyer JL, Mohanram A, Camaioni E, Jacobson KA, Harden TK (1998) Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2′-deoxyadenosine 3′,5′-bisphosphate. Br J Pharmacol 124: 1-3
6. Buxton IL, Kaiser RA, Oxhorn BC, Cheek DJ (2001) Evidence supporting the nucleotide axis hypothesis: ATP release and metabolism by coronary endothelium. Am J Physiol Heart Circ Physiol 281: H1657-H1666
7. Cao Y, Cao R (1999) Angiogenesis inhibited by drinking tea. Nature 398: 381
8. Chopra P, Singh A, Koul A, Ramachandran S, Drlica K, Tyagi AK, Singh Y (2003) Cytotoxic activity of nucleoside diphosphate kinase secreted from Mycobacterium tuberculosis. Eur J Biochem 270: 625-634
9. Clinical Trials (2006) Current avastin clinical trials. http://clinicaltrials.gov/
10. Goepfert C, Sundberg C, Sevigny J, Enjyoji K, Hoshi T, Csizmadia E, Robson S (2001) Disordered cellular migration and angiogenesis in cd39-null mice. Circulation 104: 3109-3115
11. Gounaris K, Thomas S, Najarro P, Selkirk ME (2001) Secreted variant of nucleoside diphosphate kinase from the intracellular parasitic nematode Trichinella spiralis. Infect Immun 69: 3658-3662
12. Hamby CV, Abbi R, Prasad N, Stauffer C, Thomson J, Mendola CE, Sidorov V, Backer JM (2000) Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells. Int J Cancer 88: 547-553
13. Holmgren L, O'Reilly MS, Folkman J (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1: 149-153
14. Jain RK (2001) Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 7: 987-989
15. Kaczmarek E, Erb L, Koziak K, Jarzyna R, Wink MR, Guckelberger O, Blusztajn JK, Trinkaus-Randall V, Weisman GA, Robson SC (2005) Modulation of endothelial cell migration by extracellular nucleotides: involvement of focal adhesion kinase and phosphatidylinositol 3-kinase-mediated pathways. Thromb Haemost 93: 735-742
16. Kaiser RA, Buxton IL (2001) Endothelium-dependent, MRS2179-independent actions of uridine 5′-triphosphate in guinea pig aorta. Proc West Pharmacol Soc 44: 49-51
17. Kaiser RA, Buxton IL (2002) Nucleotide-mediated relaxation in guinea-pig aorta: selective inhibition by MRS2179. Br J Pharmacol 135: 537-545
18. Kaiser RA, Oxhorn BC, Andrews G, Buxton IL (2002) Functional compartmentation of endothelial P2Y receptor signaling. Circ Res 91: 292-299
19. Kashiwagi S, Izumi Y, Gohongi T, Demou ZN, Xu L, Huang PL, Buerk DG, Munn LL, Jain RK, Fukumura D (2005) NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels. J Clin Invest 115: 1816-1827
20. Kazi A, Wang Z, Kumar N, Falsetti SC, Chan TH, Dou QP (2004) Structure-activity relationships of synthetic analogs of (-)-epigallocatechin-3- gallate as proteasome inhibitors. Anticancer Res 24: 943-954
21. Liang YC, Chen YC, Lin YL, Lin-Shiau SY, Ho CT, Lin JK (1999) Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3′-digallate. Carcinogenesis 20: 733-736
22. Malmquist NA, Anzinger JJ, Hirzel D, Buxton IL (2001) Ellagic acid inhibits nucleoside diphosphate kinase-B activity. Proc West Pharmacol Soc 44: 57-59
23. Moser TL, Kenan DJ, Ashley TA, Roy JA, Goodman MD, Misra UK, Cheek DJ, Pizzo SV (2001) Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc Natl Acad Sci USA 98: 6656-6661
24. Nickel W (2003) The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur J Biochem 270: 2109-2119
25. Okabe-Kado J, Kasukabe T (2003) Physiological and pathological relevance of extracellular NM23/NDP kinases. J Bioenerg Biomembr 35: 89-93
26. Postel EH (2003) Multiple biochemical activities of NM23/NDP kinase in gene regulation. J Bioenerg Biomembr 35: 31-40
27. Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492
28. Roymans D, Willems R, Van Blockstaele DR, Slegers H (2002) Nucleoside diphosphate kinase (NDPK/NM23) and the waltz with multiple partners: possible consequences in tumor metastasis. Clin Exp Metastasis 19: 465-476
29. Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair MG, Heber D (2005) In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem 16: 360-367
30. Sellappan S, Grijalva R, Zhou X, Yang W, Eli MB, Mills GB, Yu D (2004) Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line. Cancer Res 64: 3479-3485
31. Seye CI, Yu N, Gonzalez FA, Erb L, Weisman GA (2004) The P2Y2 nucleotide receptor mediates vascular cell adhesion molecule-1 expression through interaction with VEGF receptor-2 (KDR/Flk-1). J Biol Chem 279: 35679-35686
32. Singh AK, Seth P, Anthony P, Husain MM, Madhavan S, Mukhtar H, Maheshwari RK (2002) Green tea constituent epigallocatechin-3-gallate inhibits angiogenic differentiation of human endothelial cells. Arch Biochem Biophys 401: 29-37
33. Suganuma M, Okabe S, Kai Y, Sueoka N, Sueoka E, Fujiki H (1999) Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res 59: 44-47
34. Tanaka N, Kawasaki K, Nejime N, Kubota Y, Nakamura K, Kunitomo M, Takahashi K, Hashimoto M, Shinozuka K (2004) P2Y receptor-mediated Ca(2+) signaling increases human vascular endothelial cell permeability. J Pharmacol Sci 95: 174 -180
35. Tong RT, Boucher Y, Kozin SV, Winkler F, Hicklin DJ, Jain RK (2004) Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res 64: 3731-3736
36. White N, Burnstock G (2006) P2 receptors and cancer. Trends Pharmacol Sci 27: 211-217
37. Yamakawa S, Asai T, Uchida T, Matsukawa M, Akizawa T, Oku N (2004) (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis. Cancer Lett 210: 47-55
38. Yang S, Cheek DJ, Westfall DP, Buxton IL (1994) Purinergic axis in cardiac blood vessels. Agonist-mediated release of ATP from cardiac endothelial cells. Circ Res 74: 401-407
39. Ziche M, Morbidelli L (2000) Nitric oxide and angiogenesis. J Neurooncol 50: 139-148